Easywell Biomedicals, Inc. (TPEX:1799)
28.05
-0.05 (-0.18%)
Oct 20, 2026, 1:21 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 3.5 billion as of October 20, 2026. It is the 24,732nd most valuable company in the world and the 1,304th biggest in Taiwan. Its market cap has decreased by 36.25% in one year.
Market Cap
3.50B
Enterprise Value
3.42B
Revenue
799.94M
Global Rank
Country Rank
#1,304 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 3.50B, an increase of 681.75%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 3.50B | -21.65% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 5.72B |
| Yoda Pharmaceuticals | 5.06B |
| Panion & Bf Biotech | 4.64B |
| LIWANLI Innovation | 4.57B |
| Orient EuroPharma | 3.98B |
| Maywufa Company | 2.79B |
| Allied Biotech | 2.66B |
| Merdury Biopharmaceutical | 2.63B |